Terumo Corp., a Japanese medical technology company, won U.S. Food and Drug Administration premarket approval for its LVIS and LVIS jr. stents.
The tube-like devices are used in stent-assisted coil embolization of intracranial aneurysms, a life-threatening disorder of blood vessels in the brain in which weakness in the wall of a cerebral artery or vein causes a localized dilation or ballooning of the vessel.
LVIS and LVIS jr. are the only stents to get premarket approval from the FDA for the procedure.
Tokyo-based Terumo manufactures and sells medical devices and services and provides products for use in surgical procedures and transfusions.
